Skip to main content

Table 3 Micronutrient level versus treatment outcomes

From: Micronutrient levels and their effects on the prognosis of visceral leishmaniasis treatment, a prospective cohort study

Micronutrient

Treatment outcome

RRa [95% CI]

Successful

Not successful

Frequency

%

Frequency

%

Zinc (mcg/dl)

≤58

211

16.1

135

10.3

0.66 [0.6–0.72]

59–98

387

29.6

36

2.8

0.98 [0.95–1.02]

> 99

511

39

29

2.2

Reference group

Iodine (mcg/l)

≤113

224

17.1

109

8.3

0.69 [0.64–0.75]

114–147

247

18.9

72

5.5

0.79 [0.75–0.84]

≥148

638

48.7

19

1.5

Reference group

Iron (mcg/dl)

≤46

321

24.5

200

15.3

0.61 [0.75–0.85]

47–48

146

11.2

0

0

0.99 [0.97–1]

≥49

642

49

0

0

Reference group

Selenium (ng/ml)

≤84

264

20.2

68

5.2

0.88 [0.83–0.93]

85–105

245

18.7

71

5.4

0.85 [0.8–0.91]

≥106

600

45.8

61

4.7

Reference group

Vitamin A (mcg/dl)

≤16

233

17.8

136

10.4

0.64 [0.59–0.69]

17–31

209

16

56

4.3

0.8 [0.75–0.85]

≥32

667

51

8

0.6

Reference group

Vitamin D (ng/ml)

≤15

281

21.5

112

8.6

0.63 [0.59–0.69]

16–27

219

16.7

27

2.1

0.79 [0.75–0.85]

≥28

609

46.5

61

4.7

Reference group

  1. aRR risk ratio